Lannett acquires 23 generic drug products from Endo subsidiary

Financial terms of the deal, which includes another product that will soon be submitted for approval from the Food and Drug Administration, were not disclosed.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.